DNA damage-induced nuclear translocation of Apaf-1 is mediated by nucleoporin Nup107

Cell Cycle. 2015;14(8):1242-51. doi: 10.1080/15384101.2015.1014148.

Abstract

Beside its central role in the mitochondria-dependent cell death pathway, the apoptotic protease activating factor 1 (Apaf-1) is involved in the DNA damage response through cell-cycle arrest induced by genotoxic stress. This non-apoptotic function requires a nuclear translocation of Apaf-1 during the G1-to-S transition. However, the mechanisms that trigger the nuclear accumulation of Apaf-1 upon DNA damage remain to be investigated. Here we show that the main 4 isoforms of Apaf-1 can undergo nuclear translocation and restore Apaf-1 deficient MEFs cell cycle arrest in the S phase following genotoxic stress through activation of Chk-1. Interestingly, DNA damage-dependent nuclear accumulation of Apaf-1 occurs independently of p53 and the retinoblastoma (pRb) pathway. We demonstrated that Apaf-1 associates with the nucleoporin Nup107 and this association is necessary for Apaf-1 nuclear import. The CED-4 domain of Apaf-1 directly binds to the central domain of Nup107 in an ATR-regulated, phosphorylation-dependent manner. Interestingly, expression of the Apaf-1-interacting domain of Nup107 interfered with Apaf-1 nuclear translocation upon genotoxic stress, resulting in a marked reduction of Chk-1 activation and cell cycle arrest. Thus, our results confirm the crucial role of Apaf-1 nuclear relocalization in mediating cell-cycle arrest induced by genotoxic stress and implicate Nup107 as a critical regulator of the DNA damage-induced intra-S phase checkpoint response.

Keywords: Apaf-1; Apaf-1, apoptotic protease activating factor 1; Apoptosome; CARD, caspase activation recruitment domain; DAPI, 4′-diamino-2-phenylindole; DNA damage; GST, glutathione S-transferase; MEFs, Mouse Embryonic Fibroblasts; NSCLC, non-small cell lung cancer; Nup107; PI, propidium iodide; cell cycle; cisplatin; nuclear pore complex; nucleoporin.

MeSH terms

  • Animals
  • Apoptotic Protease-Activating Factor 1 / deficiency
  • Apoptotic Protease-Activating Factor 1 / genetics
  • Apoptotic Protease-Activating Factor 1 / metabolism*
  • Ataxia Telangiectasia Mutated Proteins / antagonists & inhibitors
  • Ataxia Telangiectasia Mutated Proteins / genetics
  • Ataxia Telangiectasia Mutated Proteins / metabolism
  • Cell Line
  • Cell Nucleus / metabolism*
  • Checkpoint Kinase 1
  • Cisplatin / toxicity
  • DNA Damage* / drug effects
  • Humans
  • Mice
  • Nuclear Pore Complex Proteins / antagonists & inhibitors
  • Nuclear Pore Complex Proteins / genetics
  • Nuclear Pore Complex Proteins / metabolism*
  • Phosphorylation / drug effects
  • Protein Binding
  • Protein Isoforms / metabolism
  • Protein Kinases / metabolism
  • RNA Interference
  • RNA, Small Interfering / metabolism
  • Retinoblastoma Protein / metabolism
  • S Phase Cell Cycle Checkpoints / drug effects
  • Tumor Suppressor Protein p53 / deficiency
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Apoptotic Protease-Activating Factor 1
  • NUP107 protein, human
  • Nuclear Pore Complex Proteins
  • Protein Isoforms
  • RNA, Small Interfering
  • Retinoblastoma Protein
  • Tumor Suppressor Protein p53
  • Protein Kinases
  • ATR protein, human
  • Ataxia Telangiectasia Mutated Proteins
  • Checkpoint Kinase 1
  • Cisplatin